The ATP Project (Antipsychotic-TEP-Psychosis)

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

June 1, 2027

Conditions

First Episose PsychosisMetabolic DiseasePsychosis; Episode

Interventions

DRUG

Antipsychotic drugs

Any Antipsychotic drugs prescripbe as standrd of care for this specific populaton

Trial Locations (1)

Hotel-Dieu CIUSSS de l'Estrie-CHUS, Sherbrooke

All Listed Sponsors

collaborator

Baszucki Brain Research Fund

OTHER

lead

Université de Sherbrooke

OTHER

NCT06651112 - The ATP Project (Antipsychotic-TEP-Psychosis) | Biotech Hunter | Biotech Hunter